Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Reports from the same study

Selected source-checked relationships. Keep these records separate, but do not count each report as an independent study or add their participant totals.

Johns Hopkins smoking cessation pilot cohort

The 2017 report follows the original 15-person pilot. Do not combine their sample sizes as independent cohorts. The later randomized smoking trial is separate. Checked 2026-11-03.

Coverage is incomplete. Missing links do not establish independence. Relationship data and source evidence (JSON).

Read this study in context

This report is included in a selected evidence comparison. Review its population, primary endpoint, findings and limitations alongside the other selected reports.

These original educational annotations are not an exhaustive systematic review or a clinical guideline.

Bibliographic context

Journal
Journal of psychopharmacology (Oxford, England)
Date
2014-11-01
Source
PubMed
DOI
10.1177/0269881114548296
PubMed
25213996
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:27 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders2026-09-02The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies2026-08-18Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework2026-08-12Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)2026-08-12Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex2026-07-28Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review2026-07-26Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions2026-07-03Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments2026-06-12Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman Spectroscopy2026-05-28Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care2026-05-14The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey2026-04-15Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)2026-03-26Psilocybin or Nicotine Patch for Smoking Cessation2026-03-10Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention2026-03-01A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations2026-02-28THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS2026-01-22

Related papers

No close related records were found yet.